Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Vincent W. Keng David A Largaespada |
| Publication date | March 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |